INSPIREMD 1/18 DL-0001 Total Liabilities
INSPIREMD 1/18 DL-0001 total liabilities. Based on the latest financial reports, INSPIREMD 1/18 DL-0001 (II2) has total liabilities worth €14.20 Million EUR (≈ $16.60 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are INSPIREMD 1/18 DL-0001's assets to evaluate the company's liquid asset resilience ratio.
Total Liabilities of INSPIREMD 1/18 DL-0001 (2021–2025)
Total liabilities of INSPIREMD 1/18 DL-0001 from 2021 to 2025. This chart illustrates how INSPIREMD 1/18 DL-0001's total liabilities have evolved over time, based on quarterly financial data.
INSPIREMD 1/18 DL-0001 Competitors by Total Liabilities
The table below lists competitors of INSPIREMD 1/18 DL-0001 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
AJ Advance Technology Public Company Limited
BK:AJA
|
Thailand | ฿117.86 Million |
|
Eden Inc Bhd
KLSE:7471
|
Malaysia | RM81.78 Million |
|
Jindo.Co. Ltd
KO:088790
|
Korea | ₩28.56 Billion |
|
Puncak Niaga Holdings Bhd
KLSE:6807
|
Malaysia | RM1.49 Billion |
|
Blackrock World Mining Trust Plc
LSE:BRWM
|
UK | GBX107.48 Million |
|
Delko S.A.
WAR:DEL
|
Poland | zł174.50 Million |
|
BCWORLD PHARM. Co. Ltd
KQ:200780
|
Korea | ₩101.30 Billion |
|
Parkway Corporate Ltd
AU:PWN
|
Australia | AU$10.29 Million |
Liability Composition Analysis (2021–2025)
This chart breaks down INSPIREMD 1/18 DL-0001's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see INSPIREMD 1/18 DL-0001 balance sheet assets.
Liquidity & Leverage Metrics
INSPIREMD 1/18 DL-0001 Total Liabilities Ratios Explained
INSPIREMD 1/18 DL-0001 total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.74 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.26 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.20 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how INSPIREMD 1/18 DL-0001's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for INSPIREMD 1/18 DL-0001 (2021–2025)
The table below shows the annual total liabilities of INSPIREMD 1/18 DL-0001 from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €14.20 Million ≈ $16.60 Million |
+32.48% |
| 2024-12-31 | €10.72 Million ≈ $12.53 Million |
+31.68% |
| 2023-12-31 | €8.14 Million ≈ $9.52 Million |
+12.15% |
| 2022-12-31 | €7.26 Million ≈ $8.49 Million |
+17.48% |
| 2021-12-31 | €6.18 Million ≈ $7.23 Million |
-- |
About INSPIREMD 1/18 DL-0001
InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard c… Read more